Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ENDRA Life Sciences (Nasdaq: NDRA) logo — Focused on early detection of liver disease

ENDRA Life Sciences (Nasdaq: NDRA)

Focused on early detection of liver disease

Founded 2009 United States Ann Arbor, United States 25 employees Post-IPO Equity Total: $8.99M Biotechnology, Health Care +1

General Information

Company Name ENDRA Life Sciences (Nasdaq: NDRA)
Founded Year 2009
Location United States Ann Arbor, United States
Employees 25
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with ENDRA Life Sciences (Nasdaq: NDRA). To contact ENDRA Life Sciences (Nasdaq: NDRA), visit endrainc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ENDRA Life Sciences (Nasdaq: NDRA) compare?

A PDF of ENDRA Life Sciences (Nasdaq: NDRA) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ENDRA Life Sciences (Nasdaq: NDRA) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ENDRA Life Sciences (Nasdaq: NDRA)

ENDRA Life Sciences Inc. (NDRA) is a biotechnology company headquartered in the United States and founded in 2007. The company's focus is on early detection of liver disease, particularly Non-Alcoholic Fatty Liver Disease (NAFLD), which affects over 1 billion people globally and is estimated to cost the U.S healthcare system over $100B annually. ENDRA is addressing the limitations of current diagnostic tools by developing a next-generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform, which aims to enable visualization of tissue composition, function, and temperature at the point-of-care, akin to capabilities offered by CT and MRI but at a fraction of the cost. ENDRA's recent funding includes a $8.70M post-IPO equity investment by Ascendiant Capital on April 21, 2022. The company's innovative approach to addressing the unmet needs in liver disease diagnosis and monitoring, coupled with its potential to significantly reduce healthcare costs, makes it an attractive prospect for venture capital investment. With the global burden of NAFLD projected to increase, ENDRA's efforts to broaden access to better healthcare through enhanced ultrasound technologies position it as a promising player in the biotechnology and healthcare industries. For further details, please visit www.endrainc.com.

Business keywords: Enhanced ultrasound technologies, TAEUS platform, Liver disease detection, Non-Alcoholic Fatty Liver Disease (NAFLD), Medical imaging technology, Point-of-care diagnostics, Liver health monitoring, Non-invasive diagnostics, Healthcare cost reduction, Early disease detection, Medical device innovation, Liver fat quantification, Medical technology startups, Healthcare accessibility

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $8.70M 1
Ascendiant Capital
Ascendiant Capital
21 Apr 2022
Venture Round $287.10K -
25 Mar 2014

ENDRA Life Sciences (Nasdaq: NDRA) Alternatives & Competitors

View All Alternatives
ENDRA Life Sciences (Nasdaq: NDRA) vs
Livivos, Inc
Livivos, Inc United States

Revolutionary Point-of-Care Liver Disease Diagnostics.

Grant
8 employees
Health Care, Manufacturing
Compare ENDRA Life Sciences (Nasdaq: NDRA) vs Livivos, Inc
ENDRA Life Sciences (Nasdaq: NDRA) vs
Arrow Dx
Arrow Dx United States

Arrow Dx is creating precision diagnostics by combining AI and nanotechnology through a versatile, p...

3 employees
Biotechnology, Health Care
Compare ENDRA Life Sciences (Nasdaq: NDRA) vs Arrow Dx
ENDRA Life Sciences (Nasdaq: NDRA) vs
Sonic Incytes Medical Corp.
Sonic Incytes Medical Corp. Canada

Creators of VELACUR: point-of-care AI guided ultrasound elastography for chronic liver diseases such...

Series A
41 employees
Health Care, Medical Devices
Compare ENDRA Life Sciences (Nasdaq: NDRA) vs Sonic Incytes Medical Corp.
Also compare with: ENDRA Life Sciences (Nasdaq: NDRA) vs SuperSonic Imagine SuperSonic Imagine View all alternatives

FAQ About ENDRA Life Sciences (Nasdaq: NDRA)

Focused on early detection of liver disease
ENDRA Life Sciences (Nasdaq: NDRA) was founded in 2009.
ENDRA Life Sciences (Nasdaq: NDRA) is headquartered in Ann Arbor, United States.
ENDRA Life Sciences (Nasdaq: NDRA) operates in Biotechnology, Health Care and Medical Devices. Its work centres on Enhanced ultrasound technologies, TAEUS platform, Liver disease detection and Non-Alcoholic Fatty Liver Disease (NAFLD).
ENDRA Life Sciences (Nasdaq: NDRA) has approximately 25 employees.
ENDRA Life Sciences (Nasdaq: NDRA) has completed 2 funding rounds, raising a total of $8.99M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to ENDRA Life Sciences (Nasdaq: NDRA) include Livivos, Inc, Arrow Dx, Sonic Incytes Medical Corp., SuperSonic Imagine, Madrigal Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ENDRA Life Sciences (Nasdaq: NDRA) and Livivos, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ENDRA Life Sciences (Nasdaq: NDRA), https://bouncewatch.com/company/endra-life-sciences-nasdaq-ndra, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout